Startup Battlefield company SpotitEarly trained dogs and AI to sniff out common cancers

SpotitEarly, an Israeli startup founded in 2020, is developing an innovative at-home cancer screening test that leverages trained dogs’ exceptional sense of smell combined with AI technology to detect early-stage cancers from human breath samples. The company employs 18 trained beagles that identify cancer-specific odors by sitting when they detect cancer particles. This canine detection is augmented by an AI platform that monitors the dogs’ behavior, breathing patterns, and heart rates to improve accuracy beyond human observation. A double-blind clinical study involving 1,400 participants demonstrated that SpotitEarly’s method can detect four common cancers—breast, colorectal, prostate, and lung—with 94% accuracy. SpotitEarly recently launched into the U.S. market with $20.3 million in funding and plans to expand its clinical trials, initially focusing on breast cancer before addressing the other cancers. The company aims to offer its multi-cancer screening kits through physicians’ networks starting next year, pricing the initial test at approximately $